NEW YORK, Sept. 27, 2016 -- A growing trend among men across the world is elective surgery to increase penis size. No longer satisfied with their defining body part, men are more and more choosing to take the matter of size straight to surgeons. Based on global survey results, the International Society of Aesthetic Plastic Surgery (ISAPS) shows that the number of penile enlargements has increased over 16% in one year.
| Penile Enlargement Number Rises among Surgical Procedures in 2015: | |||||
| 2015 | 2014 | Percentage Increase | |||
| 11,703 | 10,053 | 16.4 | % | ||
India performed the most surgeries, at 1,484 or 12.7% of that country’s total procedures, while South Korea ranks second with 1,222 surgeries and 10.4%. Colombia comes in third with 665 procedures at 5.7%. Similar to women seeking breast augmentations, men are choosing to do something about their size, and with advancements in the procedure and recovery, feel the benefits are worth seeking.
“In viewing these numbers, it becomes clear that patients are viewing surgery as a viable option in altering their physical appearance,” notes Susumu Takayanagi, MD, President of ISAPS. “For those men not happy with their size, they are making informed choices through consulting with their qualified surgeon,” he states. The results are available on the ISAPS website, http://www.isaps.org, in the News section, and will be discussed at the biennial Global Congress in Kyoto, Japan, October 23–27, 2016.
This collection of information of surgical and non-surgical treatments from 2015 was tabulated from a questionnaire sent to approximately 35,000 plastic surgeons in the ISAPS database. ISAPS is the only organization that collects this type of data on a global scale, and the study is viewed as a valuable resource in the field. The International Survey on Aesthetic/Cosmetic Procedures Performed in 2015 was compiled, tabulated, and analyzed by Industry Insights, Inc. http://www.industryinsights.com, an independent research firm based in Columbus, OH.
About ISAPS:
The International Society of Aesthetic Plastic Surgery is the premier global organization for board-certified plastic surgeons. Regarded as the leading global educator in aesthetic procedures, ISAPS offers its more than 3,200 members in 103 countries over 30 courses, workshops and symposia each year conducted by a world-class faculty with the primary goal of teaching aesthetic best practices and ensuring patient safety. Through its rigorous membership screening, ISAPS is a guardian of patient safety internationally, making it the patient’s global resource to find qualified and experienced aesthetic plastic surgeons.
Media Contact: Julie Guest, ISAPS Chief Marketing Officer [email protected] 1-844-867-3621


Korea Zinc to Build $7.4 Billion Critical Minerals Refinery in Tennessee With U.S. Government Backing
iRobot Files for Chapter 11 Bankruptcy Amid Rising Competition and Tariff Pressures
SUPERFORTUNE Launches AI-Powered Mobile App, Expanding Beyond Web3 Into $392 Billion Metaphysics Market
Treasury Wine Estates Shares Plunge on Earnings Warning Amid U.S. and China Weakness
Woolworths Faces Fresh Class Action Over Alleged Underpayments, Shares Slide
Nvidia Weighs Expanding H200 AI Chip Production as China Demand Surges
Apple Explores India for iPhone Chip Assembly as Manufacturing Push Accelerates
HSBC’s $13.6 Billion Take-Private Offer for Hang Seng Bank Gains Board Backing
Amazon in Talks to Invest $10 Billion in OpenAI as AI Firm Eyes $1 Trillion IPO Valuation
Nomura Expands Alternative Assets Strategy With Focus on Private Debt Acquisitions
Korea Zinc Plans $6.78 Billion U.S. Smelter Investment With Government Partnership
Blackstone Leads $400 Million Funding Round in Cyera at $9 Billion Valuation
Trump Sues BBC for Defamation Over Edited Capitol Riot Speech Clip
EU Signals Major Shift on 2035 Combustion Engine Ban Amid Auto Industry Pressure
Biren Technology Targets Hong Kong IPO to Raise $300 Million Amid China’s AI Chip Push
Coca-Cola’s Proposed Sale of Costa Coffee Faces Uncertainty Amid Price Dispute
FDA Says No Black Box Warning Planned for COVID-19 Vaccines Despite Safety Debate 



